Bnp Paribas Arbitrage, Snc »

Arrivent Biopharma shares owned by Bnp Paribas Arbitrage, Snc

Quarter-by-quarter ownership of Arrivent Biopharma shares owned by Bnp Paribas Arbitrage, Snc from 13F filings

Historical chart of Bnp Paribas Arbitrage, Snc investment in Arrivent Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Arrivent Biopharma held by Bnp Paribas Arbitrage, Snc consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrivent Biopharma by Bnp Paribas Arbitrage, Snc

Quarter filed Position value Share count Share price at filing
2024-03-31 $83k 4.7k 17.86

More positions owned by Bnp Paribas Arbitrage, Snc

Microsoft Corp Equity (MSFT)
Apple Equity (AAPL)
NVIDIA Corp Equity (NVDA)
Meta Platforms Equity (META)
Amazon.com Equity (AMZN)
Tesla Equity (TSLA)
Broadcom Equity (AVGO)
Alphabet Equity (GOOGL)
Advanced Micro Devices Equity (AMD)
Industrial Select Sector SPDR Fund Fund (XLI)
Exxon Mobil Corp Equity (XOM)
iShares Russell 2000 ETF Fund (IWM)
Visa Equity (V)
JPMorgan Chase & Co Equity (JPM)
Alphabet Equity (GOOG)

View all positions for Bnp Paribas Arbitrage, Snc

Top funds holding Arrivent Biopharma

OrbiMed Advisors
FMR
Octagon Capital Advisors
Sofinnova Ventures
Suvretta Capital Management
General Catalyst Group Management
Sc China Holding
BlackRock
Vanguard Group
Cormorant Asset Management
Perceptive Advisors
Citadel Advisors
Geode Capital Management
Millennium Management
Farallon Capital Management

View all funds holding Arrivent Biopharma